Agreement names Dario as the preferred digital health
provider for employer clients
NEW
YORK, Oct. 5, 2023 /PRNewswire/ -- DarioHealth
Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the
global digital health market, announced a new strategic partnership
with a top five national employee benefits consulting firm (the
"Firm"), to become the preferred digital health and chronic
condition solution partner for its national employer clients.
The Firm selected Dario for its proven ability to deliver
meaningful engagement and improved clinical results at a lower cost
than competitors. Through the preferred partnership agreement,
Dario becomes the digital chronic condition management option for
the Firm's clients looking to implement a solution to address
diabetes, pre-diabetes, hypertension, musculoskeletal and
behavioral health needs. Firm consultants now have the ability to
bring Dario's solution to their clients in unique and
differentiated ways.
Dario's suite of solutions combines innovative technologies and
clinical support for chronic conditions into a single digital
therapeutics platform, allowing each user journey to be informed by
ten years of clinical and engagement insights to keep people
engaged in healthier behaviors over time. Dario's approach is
proven to keep members engaged over time to deliver sustainable
improvements in health outcomes and lower cost of care for
clients.
"As employers increasingly turn to their trusted consultants to
help navigate decisions on digital health solutions, having the
right partners becomes even more important. We're proud to announce
this new partnership with such a respected leader in the industry
and excited to work with their team of trusted advisors to help
their clients get the best possible solution for their needs," said
Rick Anderson, President of
Dario.
About DarioHealth Corp.
DarioHealth Corp. (Nasdaq: DRIO) is a leading digital health
company revolutionizing how people with chronic conditions manage
their health through a user-centric, multi-chronic condition
digital therapeutics platform. Dario's platform and suite of
solutions deliver personalized and dynamic interventions driven by
data analytics and one-on-one coaching for diabetes, hypertension,
weight management, musculoskeletal pain and behavioral
health.
Dario's user-centric platform offers people continuous and
customized care for their health, disrupting the traditional
episodic approach to healthcare. This approach empowers people to
holistically adapt their lifestyles for sustainable behavior
change, driving exceptional user satisfaction, retention and
results and making the right thing to do the easy thing to do.
Dario provides its highly user-rated solutions globally to
health plans and other payers, self-insured employers, providers of
care and consumers. To learn more about Dario and its digital
health solutions, or for more information, visit
http://dariohealth.com.
Cautionary Note Regarding Forward-Looking Statements
This news release and the statements of representatives and
partners of DarioHealth Corp. related thereto contain or may
contain forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. Statements that
are not statements of historical fact may be deemed to be
forward-looking statements. For example, the Company is using
forward-looking statements in this press release when it
discusses the benefits that may be realized by members using
Dario's solutions. Without limiting the generality of the
foregoing, words such as "plan," "project," "potential," "seek,"
"may," "will," "expect," "believe," "anticipate," "intend,"
"could," "estimate" or "continue" are intended to identify
forward-looking statements. Readers are cautioned that certain
important factors may affect the Company's actual results and could
cause such results to differ materially from any forward-looking
statements that may be made in this news release. Factors that may
affect the Company's results include, but are not limited to,
regulatory approvals, product demand, market acceptance, impact of
competitive products and prices, product development,
commercialization or technological difficulties, the success or
failure of negotiations and trade, legal, social and economic
risks, and the risks associated with the adequacy of existing cash
resources. Additional factors that could cause or contribute to
differences between the Company's actual results and
forward-looking statements include, but are not limited to, those
risks discussed in the Company's filings with the U.S. Securities
and Exchange Commission. Readers are cautioned that actual results
(including, without limitation, the timing for and results of the
Company's commercial and regulatory plans for Dario™ as described
herein) may differ significantly from those set forth in the
forward-looking statements. The Company undertakes no obligation to
publicly update any forward-looking statements, whether as a result
of new information, future events or otherwise, except as required
by applicable law.
DarioHealth Corporate Contact
Mary Mooney
VP Marketing
+1-312-593-4280
Media Contact
Scott
Stachowiak
Scott.Stachowiak@russopartnersllc.com
+1-646-942-5630
View original
content:https://www.prnewswire.com/news-releases/dario-signs-national-preferred-partner-agreement-with-a-top-five-national-employee-benefits-consulting-firm-301948244.html
SOURCE DarioHealth Corp.
